Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | +9.38% | +9.38% | +18.64% |
Chart calendar GlycoMimetics, Inc.
Upcoming events on GlycoMimetics, Inc.
Past events on GlycoMimetics, Inc.
2024-03-04 12:50 pm | TD Cowen Health Care Conference |
2023-12-10 09:00 pm | American Society of Hematology Meeting - Poster No: 2922 |
2023-12-09 08:30 pm | American Society of Hematology Meeting - Poster No: 1492 |
2023-11-16 08:30 am | Jefferies London Healthcare Conference |
2023-11-03 08:30 am | Q3 2023 Earnings Call |
2023-11-03 07:00 am | Q3 2023 Earnings Release |
2023-09-13 11:30 am | H.C. Wainwright Global Investment Conference |
2023-08-02 08:30 am | Q2 2023 Earnings Call |
2023-08-02 07:00 am | Q2 2023 Earnings Release |
2023-06-07 04:00 pm | Jefferies Global Healthcare Conference - Fireside Chat |
2023-05-19 09:00 am | Annual General Meeting |
2023-05-03 08:30 am | Q1 2023 Earnings Call |
2023-05-03 07:00 am | Q1 2023 Earnings Release |
2023-03-29 08:30 am | Q4 2022 Earnings Call |
2023-03-29 07:00 am | Q4 2022 Earnings Release |
2023-03-08 12:50 pm | Cowen Health Care Conference - Panel |
2022-12-11 | American Society of Hematology Meeting - Publication Number: 2764 |
2022-12-10 06:30 pm | American Society of Hematology Meeting - Publication Number: 1448 |
2022-11-17 10:50 am | Jefferies London Healthcare Conference |
2022-11-14 | Stifel Healthcare Conference |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 10,2 8,40 20.99% | 1,16 1,13 2.84% | 0,08 0,05 50% | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -51,5 -50,4 -2.14% | -61,4 -61,8 0.7% | -51,5 -51,7 0.44% | -63,4 -63,9 0.68% | -47,4 -45,7 -3.66% | -39,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,3 -48,2 -0.09% | -57,9 -57,2 -1.23% | -51,0 -50,7 -0.72% | -63,4 -62,2 -1.97% | -46,7 -45,9 -1.72% | -37,4 |
Net income Million USD | Released Forecast Spread | -48,3 -47,8 -0.9% | -57,9 -57,3 -0.97% | -51,0 -50,9 -0.25% | -63,4 -63,6 0.32% | -46,7 -45,4 -2.75% | -37,5 |
EPS USD | Released Forecast Spread | -1,18 -1,16 -1.72% | -1,34 -1,31 -2.16% | -1,12 -1,11 -0.54% | -1,23 -1,25 1.4% | -0,89 -0,87 -2.3% | -0,60 |
Announcement Date | 06/03/19 | 28/02/20 | 02/03/21 | 03/03/22 | 29/03/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,09 0,00 - | 0,02 0,00 - | 0,00 0,00 - | 0,08 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,03 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -17,3 -16,4 -5.67% | -17,4 -17,9 2.75% | -14,7 -16,2 9.44% | -13,4 -14,8 9.69% | -8,77 -14,2 38.38% | -10,6 -8,91 -19.23% | -10,9 -10,4 -5.51% | -8,93 -11,2 20.52% | -9,81 -9,27 -5.88% | -10,1 | -10,2 | -10,4 | -10,6 | -10,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,3 -13,2 -31.3% | -17,4 -16,3 -6.88% | -14,7 -15,6 5.77% | -13,3 -15,1 12.14% | -8,52 -15,7 45.71% | -10,2 -9,00 -13.83% | -10,4 -11,0 5.83% | -8,26 -13,4 38.37% | -9,20 -9,40 2.1% | -9,59 | ||||
Net income Million USD | Released Forecast Spread | -17,3 -16,1 -7.37% | -17,4 -17,7 1.46% | -14,7 -16,0 8.35% | -13,3 -14,8 10.25% | -8,52 -14,2 40% | -10,2 -8,84 -15.89% | -10,4 -10,3 -1.04% | -8,26 -11,6 29.04% | -9,20 -9,07 -1.48% | -9,72 | -10,2 | -10,4 | -10,6 | -10,8 |
EPS USD | Released Forecast Spread | -0,34 -0,32 -7.09% | -0,33 -0,34 3.65% | -0,28 -0,31 8.7% | -0,25 -0,29 12.28% | -0,16 -0,26 39.24% | -0,19 -0,17 -14% | -0,17 -0,17 -2% | -0,13 -0,18 29.09% | -0,14 -0,14 2.32% | -0,15 | -0,16 | -0,16 | -0,16 | -0,17 |
Announcement Date | 02/11/21 | 03/03/22 | 28/04/22 | 03/08/22 | 09/11/22 | 29/03/23 | 03/05/23 | 02/08/23 | 03/11/23 | - | - | - | - | - |
Past sector events for GlycoMimetics, Inc.
2024-03-18 04:15 pm | ALPINE IMMUNE SCIENCES, INC.: Q4 2023 Earnings Release |
2024-03-17 | WUXI APPTEC CO., LTD.: Q4 2023 Earnings Release |
2024-03-17 | AKESO, INC.: Q4 2023 Earnings Release |
2024-03-14 04:05 pm | LARIMAR THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-14 04:05 pm | ALLOGENE THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-14 07:00 am | AUTOLUS THERAPEUTICS PLC: Q4 2023 Earnings Release |
2024-03-13 | CABALETTA BIO, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-12 04:01 pm | LONGBOARD PHARMACEUTICALS, INC.: Q4 2023 Earnings Release |
2024-03-11 04:15 pm | ANAPTYSBIO, INC.: Q4 2023 Earnings Release |
2024-03-11 04:05 pm | ORIC PHARMACEUTICALS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock GlycoMimetics, Inc. - Nasdaq
- Calendar GlycoMimetics, Inc.